Skip to content

Techniques for Activating Consciousness (TAC) for Outpatients With Moderate to Severe Alcohol Addiction

Randomized Controlled Trial to Evaluate the Efficacy of Hypnosis and Learning Self-exercises for Outpatients With Moderate to Severe Alcohol Addiction

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07369245
Acronym
TAC-ADDICT
Enrollment
98
Registered
2026-01-27
Start date
2026-04-15
Completion date
2028-01-15
Last updated
2026-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Addiction

Keywords

Hypnotic therapy, Techniques for Activating Consciousness (TAC), Alcohol addiction

Brief summary

Many patients are considering the use of so-called "hypnosis" treatments in the field of addictions. However, these techniques lack sufficient levels of evidence with regard to the standards required by Evidence-Based Medicine. In other domains, however, hypnosis has demonstrated an interesting level of evidence, particularly in pain management. The investigators will focus on the "Techniques for Activating Consciousness" (TAC), which represent an optimized therapeutic approach derived from hypnotic therapy.

Interventions

BEHAVIORALTAC intervention

Patients receiving TAC (Techniques for Activating Consciousness) intervention in addition to standard care

Sponsors

Versailles Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients consulting for an alcohol-related addiction problem at the CSAPA of Versailles (sites in Versailles, Trappes, Rambouillet) or at the Centre Hospitalier des 4 Villes (day hospital or CSAPA in Sèvres) * Patients must meet at least 4 of the 11 DSM-5 criteria (Annex 2), corresponding to moderate to severe addiction * Patients must be affiliated with the French social security system

Exclusion criteria

* Refusal to participate * Decompensated psychiatric pathology contraindicating therapy: * Presence at inclusion of delusional, dissociative, and/or persecutory symptoms * Presence at inclusion of hypomanic or manic decompensation * Severe cognitive impairment, evidenced by inability to perform the clock-drawing test (draw the clock face, place the numbers, and set the hands to 11:10) * Adults legally protected under French law (deprivation of liberty, legal safeguard, guardianship, curatorship) * Inability to understand French

Design outcomes

Primary

MeasureTime frameDescription
The patient's ability to control alcohol consumption during outpatient follow-up in a CSAPA6 monthsThe main outcome measure will be the number of weeks to achieve the targeted goal between T0 (first consultation when the objective is set) and M6 (cumulative time).

Secondary

MeasureTime frameDescription
Controlling addictive behavior in both groups12 monthsEvaluation criteria for both groups: * Cumulative time over 12 months during which the subject meets the target of controlling addictive behavior; percentage of time at target between T0-M6 and T0-M12; number of weeks to reach the target; number of relapses between T0-M6 and T0-M12; time between achieving the target and relapse between T0-M12 * Craving intensity (weekly via electronic patient questionnaire) * Levels of anxiety and depression (HAD scale) and global relaxation (IERS-3), at T0, M6, and M12 * Care received (interventions, medications) from medical records at M6 and M12 * Patient opinion questionnaire at M6 and M12 on what was perceived as useful or not in their treatment
Evaluation criteria for the TAC group12 monthsWeekly self-reports (via electronic patient questionnaire) on the frequency of exercise practice, perceived effectiveness of TAC (Techniques for Activating Consciousness) on their addictive issues (VAS 0-10), and tolerance of TAC (Techniques for Activating Consciousness)

Countries

France

Contacts

CONTACTClaire FARINA, Dr
cfarina@ght78sud.fr01 39 63 93 80
CONTACTNadia YOUNES, Dr
nyounes@ght78sud.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 17, 2026